|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q42813775
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241120235914.0 |
|
008
|
|
|
241120nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q42813775
|
|
024
|
|
|
‡a
0000-0003-4860-3399
‡2
orcid
|
|
024
|
|
|
‡a
55312630000
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q42813775
|
|
100
|
0 |
|
‡a
André Steven
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
André Steven
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells
|
|
670
|
|
|
‡a
Author's Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo.
|
|
670
|
|
|
‡a
Author's Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target
|
|
670
|
|
|
‡a
Author's HER-2/neu-mediated down-regulation of biglycan associated with altered growth properties
|
|
670
|
|
|
‡a
Author's HER-2/neu mediates oncogenic transformation via altered CREB expression and function.
|
|
670
|
|
|
‡a
Author's Hypoxia-mediated alterations and their role in the HER-2/neuregulated CREB status and localization
|
|
670
|
|
|
‡a
Author's Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity
|
|
670
|
|
|
‡a
Author's LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
|
|
909
|
|
|
‡a
(orcid) 0000000348603399
‡9
1
|
|
909
|
|
|
‡a
(scopus) 55312630000
‡9
1
|
|
919
|
|
|
‡a
hypoxiamediatedalterationsandtheirroleintheher2neuregulatedcrebstatusandlocalization
‡A
Hypoxia-mediated alterations and their role in the HER-2/neuregulated CREB status and localization
‡9
1
|
|
919
|
|
|
‡a
colorectalcarcinogenesisconnectingkrasinducedtransformationandcrebactivityinvitroandinvivo
‡A
Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo.
‡9
1
|
|
919
|
|
|
‡a
controlofcrebexpressionintumorsfrommolecularmechanismsandsignaltransductionpathwaystotherapeutictarget
‡A
Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target
‡9
1
|
|
919
|
|
|
‡a
her2neumediateddownregulationofbiglycanassociatedwithalteredgrowthproperties
‡A
HER-2/neu-mediated down-regulation of biglycan associated with altered growth properties
‡9
1
|
|
919
|
|
|
‡a
her2neumediatesoncogenictransformationviaalteredcrebexpressionandfunction
‡A
HER-2/neu mediates oncogenic transformation via altered CREB expression and function.
‡9
1
|
|
919
|
|
|
‡a
biglycanasapotentialregulatoroftumorgenicityandimmunogenicityinkrastransformedcells
‡A
Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells
‡9
1
|
|
919
|
|
|
‡a
ldhaassociatedlacticacidproductionbluntstumorimmunosurveillancebytandnkcells
‡A
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
‡9
1
|
|
919
|
|
|
‡a
inhibitionoftumorderivedprostaglandine2blockstheinductionofmyeloidderivedsuppressorcellsandrecoversnaturalkillercellactivity
‡A
Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
SUDOC|161862276
|
|
996
|
|
|
‡2
ISNI|0000000499861109
|
|
996
|
|
|
‡2
BNF|17908724
|
|
996
|
|
|
‡2
ISNI|0000000043746954
|
|
996
|
|
|
‡2
NLA|000036027329
|
|
996
|
|
|
‡2
SUDOC|276697189
|
|
996
|
|
|
‡2
LC|nb2004029315
|
|
996
|
|
|
‡2
DNB|1055982353
|
|
996
|
|
|
‡2
PLWABN|9811738829605606
|
|
996
|
|
|
‡2
NTA|316117498
|
|
996
|
|
|
‡2
BIBSYS|1632996806257
|
|
996
|
|
|
‡2
BIBSYS|97010106
|
|
996
|
|
|
‡2
LC|n 93023200
|
|
996
|
|
|
‡2
LC|no2018160745
|
|
996
|
|
|
‡2
LIH|LNB:C41_g_;=BF
|
|
996
|
|
|
‡2
LC|n 98091510
|
|
996
|
|
|
‡2
ISNI|0000000032545233
|
|
996
|
|
|
‡2
ISNI|0000000504673541
|
|
996
|
|
|
‡2
NDL|00475616
|
|
996
|
|
|
‡2
NUKAT|n 2013137362
|
|
996
|
|
|
‡2
N6I|vtls000001275
|
|
996
|
|
|
‡2
DNB|173062539
|
|
996
|
|
|
‡2
ISNI|0000000033624507
|
|
996
|
|
|
‡2
CAOONL|ncf11749743
|
|
996
|
|
|
‡2
ISNI|0000000034632648
|
|
996
|
|
|
‡2
NTA|072977124
|
|
996
|
|
|
‡2
LC|n 86105485
|
|
996
|
|
|
‡2
ISNI|0000000066211047
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
